What is the route of administration for Trogarzo (Ibalizumab)?

Trogarzo (Ibalizumab) is administered via the intravenous route. This method allows for direct delivery of the medication into the bloodstream, which can lead to rapid onset of action and higher bioavailability compared to other routes like oral or subcutaneous. Intravenous administration is particularly beneficial for medications that require immediate therapeutic effects or for patients who may have difficulty administering medications themselves, such as those with certain medical conditions.

In the case of Trogarzo, which is used as a treatment for HIV, the intravenous route ensures that the drug reaches therapeutic levels quickly and can effectively target the virus by blocking its entry into immune cells. This mechanism is crucial for the treatment of HIV-positive patients, especially those with multi-drug resistant strains. Using other routes such as intramuscular, subcutaneous, or oral would not achieve the same rapid and effective results in managing HIV viral load.